Dynavax Technologies Corporation(NASDAQ:DVAX) 
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older ...
Website: http://www.dynavax.com
Founded: 1996
Full Time Employees: 231
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 12.75
H 12.87
L 12.49
C 12.65
V 2,341,420
10EMA 12.65
20EMA 12.65
60EMA 12.65
120EMA 12.65
250EMA 12.65